The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test

Neuroscience Letters

Volumn 612, Issue , 2016, Pages 52-61

  Khan, Muhammad Imran ^a,b,e   Ostadhadi, Sattar ^b,c   Zolfaghari, Samira ^d   Ejtemaei Mehr, Shahram ^a,b   Hassanzadeh, Gholamreza ^e   Dehpour, Ahmad Reza ^a,b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Baclofen; Depression; Forced swimming test; Mice; N methyl d aspartate (NMDA); Nitric oxide

Indexed keywords

7 NITROINDAZOLE; ARGININE; BACLOFEN; CYCLIC GMP; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V; SILDENAFIL; 7-NITROINDAZOLE; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; DIZOCILPINE MALEATE; INDAZOLE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; FORCED SWIM TEST; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG THERAPY; MENTAL STRESS; METABOLISM; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; BACLOFEN; CYCLIC GMP; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; INDAZOLES; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE 5 INHIBITORS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SILDENAFIL CITRATE; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84954159392     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.12.006     Document Type: Article

References (36)

1. Renaud J., Bédard E. Depression in the elderly with visual impairment and its association with quality of life. Clin. Interv. Aging 2013, 8:931-943.
2. Nemeroff C.B., Owens M.J. Treatment of mood disorders. Nat. Neurosci. 2002, 5:1068-1070.
3. Pilc A., Nowak G. GABAergic hypotheses of anxiety and depression: focus on GABAB receptors. Drugs Today 2005, 41:755-766.
4. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety-and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
5. Frankowska M., Filip M., Przegaliñski E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol. Rep. 2007, 59:645-655.
6. Zhou C., Li C., Yu H.M., Zhang F., Han D., Zhang G.Y. Neuroprotection of γ-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. J. Neurosci. Res. 2008, 86:2973-2983.
7. Chalifoux J.R., Carter A.G. GABA B. receptors modulate NMDA receptor calcium signals in dendritic spines. Neuron 2010, 66:101-113.
8. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel improved therapeutics for mood disorders. Nat. Rev. Drug. Discov. 2008, 7:426-437.
9. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
10. Rogóz Z., Skuza G., Maj J., Danysz W. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 2002, 42:1024-1030.
11. Harkin A., Connor T.J., Burns M.P., Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 2004, 14:274-281.
12. Esplugues J.V. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 2002, 135:1079-1095.
13. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science (New York, N.Y.) 1992, 257:494.
14. Haj-Mirzaian A., Ostadhadi S., Kordjazy N., Dehpour A.R., Mehr S.E. Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test. Eur. J. Pharmacol. 2014, 735:26-31.
15. Kordjazy N., Haj-Mirzaian A., Amiri S., Ostadhadi S., Kordjazy M., Sharifzadeh M., et al. Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice. Eur. J. Pharmacol. 2015, 762:411-418.
16. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.) 2005, 177:245-255.
17. Sadaghiani M.S., Javadi-Paydar M., Gharedaghi M.H., Fard Y.Y., Dehpour A.R. Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Behav. Brain Res. 2011, 224:336-343.
18. Ghasemi M., Montaser-Kouhsari L., Shafaroodi H., Nezami B.G., Ebrahimi F., Dehpour A.R. NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology (Berl.) 2009, 206:325-333.
19. Kaster M.P., Rosa A.O., Santos A.R., Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 2005, 8:601-606.
20. Nakagawa Y., Ishima T., Ishibashi Y., Tsuji M., Takashima T. Involvement of GABA B receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats. Brain Res. 1996, 741:240-245.
21. Aley K., Kulkarni S. Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice. Arch. Int. Pharmacodyn. Ther. 1989, 307:18-31.
22. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 2002, 23:238-245.
23. Car H., Wiśniewska R. Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats. Pharmacol. Rep. 2005, 58:758-764.
24. Slattery D.A., Desrayaud S., Cryan J.F. GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J. Pharmacol. Exp. Ther. 2005, 312:290-296.
25. Filip M., Frankowska M., Przegaliński E. Effects of GABA B receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur. J. Pharmacol. 2007, 574:148-157.
26. Isaacson J., Solis J., Nicoll R. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 1993, 10:165-175.
27. Haj-Mirzaian A., Kordjazy N., Haj-Mirzaian A., Ostadhadi S., Ghasemi M., Amiri S., et al. Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests. Psychopharmacology (Berl.) 2015, 232:3551-3561.
28. Ghasemi M., Raza M., Dehpour A. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. J. Psychopharmacol. 2009, 24:85-94.
29. Morrisett R., Mott D., Lewis D., Swartzwelder H.S., Wilson W. GABAB-receptor-mediated inhibition of the N-methyl-d-aspartate component of synaptic transmission in the rat hippocampus. J. Neurosci. 1991, 11:203-209.
30. Otmakhova N.A., Lisman J.E. Contribution of Ih and GABAB to synaptically induced afterhyperpolarizations in CA1: a brake on the NMDA response. J. Neurophysiol. 2004, 92:2027-2039.
31. Moncada S., Bolaños J.P. Nitric oxide cell bioenergetics and neurodegeneration. J. Neurochem. 2006, 97:1676-1689.
32. Heiberg I.L., Wegener G., Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 2002, 134:479-484.
33. Ghasemi M., Sadeghipour H., Mosleh A., Sadeghipour H.R., Mani A.R., Dehpour A.R. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur. Neuropsychopharmacol. 2008, 18:323-332.
34. Dhir A., Kulkarni S. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:921-925.
35. Harkin A., Connor T., Walsh M., ST.John N., Kelly J. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 2003, 44:616-623.
36. Beavo J.A. nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 1995, 75:725-748.